申请人:HEPTARES THERAPEUTICS LTD
公开号:WO2014006402A1
公开(公告)日:2014-01-09
The disclosures herein relate to novel compounds of formula wherein W, X and Y1, Y2, Y3 and Y4 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of neurological or psychiatric disorders associated with orexin receptors.
本公开涉及一种新型化合物的公式,其中W、X和Y1、Y2、Y3和Y4在此处定义,并其在治疗、预防、改善、控制或减少与促觉素受体相关的神经系统或精神障碍的风险中的用途。